Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 17 (CCDC17) is a human protein encoded by the CCDC17 gene (NCBI Gene ID: 149483; UniProtKB: Q96LX7) characterized by multiple coiled-coil domains[5]. Immunostaining studies demonstrate that CCDC17 localizes to both the tip and basal body regions of cilia, suggesting a putative role in ciliary structure or function; however, its precise biological function is not well-defined[2]. Recent epigenetic analyses have revealed hypermethylation of CCDC17 in keratoacanthoma samples, implicating altered gene regulation in this self-limiting epidermal tumor, and there is some connection to colorectal adenocarcinoma, though mechanistic details remain unclear[4]. Overall, CCDC17 is not currently recognized as a therapeutic target, nor are there known drugs, biomarkers, or safety risks associated with its modulation. It is primarily classified as a structural protein with possible involvement in organelle architecture, typical of coiled-coil domain proteins[1][2][3][4][5].
None reported. No targeted therapeutics or mechanism defined for drug-targeting CCDC17
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 17 (CCDC17).